PM

Poonam Mall

Active Director Director DIN 05344312
DIN 05344312 First appointment Aug 2012 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2012
Shareholding value •••• Premium profile

About Poonam Mall

Data last updated:

Poonam Mall is a Director at Neowick Pharmaceuticals Private Limited (since 2012). The company operates in Chemicals. Neowick Pharmaceuticals Private Limited reported revenue of ₹11.9 Lakh (FY 2024).

DIN 05344312
Primary Designation Director
Industry Chemicals
First Appointment 08 Aug 2012
Oldest Company Age 14 yrs
Largest company Neowick Pharmaceuticals Private Limited · ₹11.9 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Aug 20122012₹11.9 Lakh (FY 2024)Active

Directorship timeline

Open interactive timeline →
Neowick Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Poonam Mall

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Poonam Mall

Poonam Mall currently holds 1 directorship: Neowick Pharmaceuticals Private Limited (Director, since 08 Aug 2012, revenue ₹11.9 Lakh (FY 2024)).

Poonam Mall was first appointed on 08 Aug 2012 as Director at Neowick Pharmaceuticals Private Limited.

The current boards of Poonam Mall's companies include Ajay Kumar Mall (Neowick Pharmaceuticals Private Limited), Ashutosh Kumar Singh (Neowick Pharmaceuticals Private Limited), Priyanka Singh (Neowick Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available